JP2004513150A5 - - Google Patents

Download PDF

Info

Publication number
JP2004513150A5
JP2004513150A5 JP2002540749A JP2002540749A JP2004513150A5 JP 2004513150 A5 JP2004513150 A5 JP 2004513150A5 JP 2002540749 A JP2002540749 A JP 2002540749A JP 2002540749 A JP2002540749 A JP 2002540749A JP 2004513150 A5 JP2004513150 A5 JP 2004513150A5
Authority
JP
Japan
Prior art keywords
factor xiii
therapeutic agent
hemophilia
administered
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002540749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004513150A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/047144 external-priority patent/WO2002038167A2/en
Publication of JP2004513150A publication Critical patent/JP2004513150A/ja
Publication of JP2004513150A5 publication Critical patent/JP2004513150A5/ja
Pending legal-status Critical Current

Links

JP2002540749A 2000-11-10 2001-11-08 Ｂ型血友病の治療方法 Pending JP2004513150A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24736200P 2000-11-10 2000-11-10
PCT/US2001/047144 WO2002038167A2 (en) 2000-11-10 2001-11-08 Use of factor xiii for treating hemophilia b

Publications (2)

Publication Number Publication Date
JP2004513150A JP2004513150A (ja) 2004-04-30
JP2004513150A5 true JP2004513150A5 (enExample) 2005-07-21

Family

ID=22934628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002540749A Pending JP2004513150A (ja) 2000-11-10 2001-11-08 Ｂ型血友病の治療方法

Country Status (8)

Country Link
EP (1) EP1351706B1 (enExample)
JP (1) JP2004513150A (enExample)
AT (1) ATE367824T1 (enExample)
AU (1) AU2002226004A1 (enExample)
CA (1) CA2429018A1 (enExample)
DE (1) DE60129599T2 (enExample)
ES (1) ES2288524T3 (enExample)
WO (1) WO2002038167A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008510476A (ja) 2004-08-27 2008-04-10 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 生物学的材料からのｘｉｉｉ因子ポリペプチドの精製
JP5086093B2 (ja) 2004-11-23 2012-11-28 ジモジェネティクス、インコーポレイテッド 組換え型ヒトｘｉｉｉ因子の精製

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2423988A (en) * 1987-08-17 1989-03-09 Liposome Company, Inc., The A sponge enzyme having transglutaminase-like activity
WO2001085198A1 (en) * 2000-05-10 2001-11-15 Novo Nordisk A/S tHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIA AND A FACTOR XIII

Similar Documents

Publication Publication Date Title
JP2006501240A5 (enExample)
JP2003503454A5 (enExample)
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
JP2014530874A5 (enExample)
JP2012532874A5 (enExample)
CN1545409A (zh) 二苯乙烯类化合物在制备用于治疗和预防糖尿病或与逆转录病毒有关疾病的药物中用途
MEP36608A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
JP2007504174A5 (enExample)
GEP20063799B (en) Tropane derivatives useful in therapy
JP2009500443A5 (enExample)
ATE444067T1 (de) Neue arzneimittelkompositionen auf der basis von tiotropiumsalzen und ciclesonide
JP2002528502A5 (enExample)
JP2015524444A5 (enExample)
JP2017506624A5 (enExample)
JP2005507892A5 (enExample)
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
JP2005508963A5 (enExample)
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
JP2003526626A5 (enExample)
JP2005500277A5 (enExample)
JP2003528919A5 (enExample)
WO2003008637A3 (en) Use of genotyping in the individualization of therapy
JP2002540148A5 (enExample)
JP2009516719A5 (enExample)